JPRN-UMIN000038202暂停未知
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid TMVR System in Patients With Severe Symptomatic Mitral Regurgitation (APOLLO) - APOLLO Trial
适应症
试验速览
- 阶段
- 未知
- 状态
- 暂停
- 入组人数
- 1,350
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Refer Protocol for details. 1. Estimated life expectancy of less than 24 months due to associated non-cardiac comorbid conditions 2. Currently implanted mitral valve 3. Prior transcatheter mitral valve procedure with device currently implanted 4. Anatomic contraindications for Intrepid TMVR System (e.g., annular dimensions, high risk of LVOT obstruction, system access, etc. 5. Anatomically prohibitive mitral annular calcification (MAC) 6. Aortic valve disease requiring intervention or previous intervention within 90 days of enrollment 8. Moderate or greater tricuspid regurgitation with echocardiographic evidence of significantly impaired right ventricular function as assessed by the echo core lab 12. Left ventricular ejection fraction (LVEF) <30% measured by resting transthoracic echocardiogram 14. Hypertrophic cardiomyopathy, restrictive cardiomyopathy, constrictive pericarditis, or other structural heart disease causing heart failure other than dilated ischemic or non-ischemic cardiomyopathy 17. Need for emergent or urgent cardiac or non-cardiac surgery 18. Hemodynamic instability requiring dependency of either inotropic agents or mechanical circulatory support 26. Untreated clinically significant coronary artery disease requiring revascularization 32. End stage renal disease requiring chronic dialysis or creatinine clearance < 45 cc/min within 30 days of the Index Procedure 33. Liver failure (Child-Pugh-C) 34. Any Cancer requiring active treatment or with life expectancy less than 24 months 35. Severe Chronic Obstructive Pulmonary Disease (COPD) demonstrated by Forced Expiratory Volume (FEV1) < 750cc, continuous home oxygen therapy, or chronic outpatient oral steroid use 36. Frailty assessments 39. Severe dementia
研究者
相似试验
招募中
不适用
Transcatheter Mitral Valve Replacement with the Medtronic Intrepid* TMVR Transfemoral System in patients with severe symptomatic mitral regurgitation - APOLLO-EU Trialleaking heart valve10046973mitral regurgitationNL-OMON56063Medtronic B.V.24
招募中
不适用
Transcatheter Aortic Valve Replacement With the Medtronic Transcatheter Aortic Valve Replacement System In Patients at Low Risk for Surgical Aortic Valve ReplacementNL-OMON53079Medtronic B.V.60
已完成
不适用
Stentless mitral valve replacement using autologous pericardium studyMitral regurgitationJPRN-UMIN000012659Sakakibara Heart Institute25
已完成
不适用
Stentless mitral valve replacement using autologous pericardium studyMitral valve diseaseJPRN-UMIN000021445Keio University School of Medicine30
暂停
不适用
Stentless mitral valve replacement using autologous pericardium studyMitral regurgitationJPRN-jRCT1032180087Shimokawa Tomoki25